2-aminoadipic acid has been researched along with adenosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akamatsu, K; Kamatani, N; Kawamura, A; Mihara, M; Suzuki, T; Takeda, Y; Urakawa, K | 1 |
| Asakura, M; Asanuma, H; Hori, M; Kitakaze, M; Minamino, T; Mori, H; Node, K; Ogai, A; Ogita, H; Sanada, S; Shinozaki, Y; Takashima, S; Tomoike, H | 1 |
2 other study(ies) available for 2-aminoadipic acid and adenosine
| Article | Year |
|---|---|
Polyglutamation of antifolates is not required for induction of extracellular release of adenosine or expression of their anti-inflammatory effects.
Topics: 2-Aminoadipic Acid; Adenosine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Cell Line; Extracellular Space; Female; Folic Acid Antagonists; Humans; Methotrexate; Mice; Mice, Inbred BALB C; Pteroylpolyglutamic Acids | 2000 |
Methotrexate and MX-68, a new derivative of methotrexate, limit infarct size via adenosine-dependent mechanisms in canine hearts.
Topics: 2-Aminoadipic Acid; Adenosine; Animals; Cardiotonic Agents; Dogs; Methotrexate; Myocardial Infarction; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Theophylline | 2004 |